Weng J - Search Results

1

Unveiling miRNA30b's Role in Suppressing ADAM12 to Combat Triple-Negative Breast Cancer.

Yin QH, Hu JB, Zhou Q, Weng J, Shen ED, Wen F, Liu SL, Yin LL, Tong YJ, Long L, Tang KW, Bai ST, Ou LD. Yin QH, et al. Among authors: weng j. Breast J. 2024 Oct 30;2024:5202941. doi: 10.1155/2024/5202941. eCollection 2024. Breast J. 2024. PMID: 39742357 Free PMC article.

2

Fabrication of bimetallic Ag@ZnO nanocomposite and its anti-cancer activity on cervical cancer via impeding PI3K/AKT/mTOR pathway.

Yin Q, Zhou Q, Hu J, Weng J, Liu S, Yin L, Long L, Tong Y, Tang K, Bai S, Ou L. Yin Q, et al. Among authors: weng j. J Trace Elem Med Biol. 2024 Jul;84:127437. doi: 10.1016/j.jtemb.2024.127437. Epub 2024 Mar 20. J Trace Elem Med Biol. 2024. PMID: 38564977

3

Role of autophagy-related genes in liver cancer prognosis.

Zhou Y, Shan R, Xie W, Zhou Q, Yin Q, Su Y, Xiao J, Luo P, Yao X, Fang J, Wen F, Shen E, Weng J. Zhou Y, et al. Among authors: weng j. Genomics. 2024 May;116(3):110852. doi: 10.1016/j.ygeno.2024.110852. Epub 2024 May 3. Genomics. 2024. PMID: 38703969 Free article.

4

A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer.

Zhan G, Hu J, Da S, Weng J, Zhou C, Wen F, Liu S, Fang F, Shen E, Zhou Q, Luo P, Xu M, Zhan D, Su Y. Zhan G, et al. Among authors: weng j. Front Endocrinol (Lausanne). 2023 Jan 20;14:1110624. doi: 10.3389/fendo.2023.1110624. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36742383 Free PMC article.

5

CircKIF4A combines EIF4A3 to stabilize SDC1 expression to activate c-src/FAK and promotes TNBC progression.

Luo P, Gong Y, Weng J, Wen F, Luo J, Hu C, Xiao J, Shu J. Luo P, et al. Among authors: weng j. Cell Signal. 2023 Aug;108:110690. doi: 10.1016/j.cellsig.2023.110690. Epub 2023 Apr 28. Cell Signal. 2023. PMID: 37121557

6

The APE1 Asp148Glu polymorphism and colorectal cancer susceptibility: a meta-analysis.

Shen E, Liu C, Wei L, Hu J, Weng J, Yin Q, Wang Y. Shen E, et al. Among authors: weng j. Tumour Biol. 2014 Mar;35(3):2529-35. doi: 10.1007/s13277-013-1334-6. Epub 2013 Nov 20. Tumour Biol. 2014. PMID: 24254302

7

The clinical value of local consolidative therapy for oligo-residual disease in PD-1/PD-L1 inhibitors-treated non-small cell lung cancer.

Su Y, Luo P, Ni L, Hu J, Weng J, Shen E, Zhou Q, Chen T, Xiao J, Xiao J, Xie W, Shan R, Yao X, Wen F. Su Y, et al. Among authors: weng j. Front Immunol. 2024 Dec 17;15:1525236. doi: 10.3389/fimmu.2024.1525236. eCollection 2024. Front Immunol. 2024. PMID: 39742281 Free PMC article.

8

Quantitative assessment of the association between XPG Asp1104His polymorphism and bladder cancer risk.

Liu C, Yin Q, Hu J, Weng J, Wang Y. Liu C, et al. Among authors: weng j. Tumour Biol. 2014 Feb;35(2):1203-9. doi: 10.1007/s13277-013-1161-9. Epub 2013 Sep 6. Tumour Biol. 2014. PMID: 24061640 Review.

9

A pooled analysis of the ERCC2 Asp312Asn polymorphism and esophageal cancer susceptibility.

Wen F, Zhao Z, Liu C, Yin Q, Weng J, Wang Y, Ma Y. Wen F, et al. Among authors: weng j. Tumour Biol. 2014 Apr;35(4):2959-65. doi: 10.1007/s13277-013-1380-0. Tumour Biol. 2014. PMID: 24234258

10

In vitro enzyme characterization and several inhibitors for monkeypox virus core protease I7L.

Wei L, Wu Y, Li S, Weng J, Geng M, Mei M, Wei Z. Wei L, et al. Among authors: weng j. FEMS Microbiol Lett. 2025 Jan 17:fnaf008. doi: 10.1093/femsle/fnaf008. Online ahead of print. FEMS Microbiol Lett. 2025. PMID: 39824654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,746 results

Search Page

Filters